Trial to Examine Text-message Based mHealth in Emergency Department Patients With Diabetes

Diabetes Clinical Trial

— TExT-MED  

Official title:

Trial to Examine Text-message Based mHealth in Emergency Department Patients With Diabetes

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01403831
• Other study ID #: HS-11-00084
• Secondary ID: Mobilizing for H
• Status: Completed
• Phase: N/A
• First received: July 25, 2011
• Last updated: June 18, 2013
• Start date: July 2011
• Est. completion date: July 2012

Study information

• Verified date: June 2013
• Source: University of Southern California
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: University of Southern California Department of Emergency Medicine
• Study type: Interventional

Clinical Trial Summary

The investigators propose an innovative, ED-based mHealth intervention: TExT-MED (Trial to Examine Text-Based mHealth for Emergency department patients with Diabetes). TExT-MED is a technologically simple solution using unidirectional daily text messages to consisting of educational materials, trivia questions and challenges promoting healthy lifestyle choices and reminders to check blood sugar, take medications and go to clinic appointments. The investigators believe TExT-MED will improve health outcomes including blood glucose control and encourage weight loss, healthy eating and exercise. TExT-MED is low cost, easy to use and can be quickly adapted to other practice environments.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 200
• Est. completion date: July 2012
• Est. primary completion date: July 2012
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years to 80 Years

Eligibility

Inclusion Criteria:

1) =18 years old 2) have Type 2 diabetes 3) have a text message capable mobile phone 4) know how to receive text messages 5) speak and read English or Spanish and 6) have a HbA1C =8%.

Exclusion Criteria:

1) overt psychosis 2) unable to provide informed consent and 3) pregnancy.

Study Design

Allocation: Randomized, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Health Services Research

Related Conditions & MeSH terms

• Diabetes

Intervention

Other:
• Daily text messages
2-3 times daily text messages regarding diabetes care and healthy lifestyle choices

Locations

Country	Name	City	State
United States	University of Southern California	Los Angeles	California

Sponsors (1)

Lead Sponsor	Collaborator
University of Southern California

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Hemoglobin A1C at 6 months		6 months	No
Secondary	DIet/ Weight Loss		6 months	No
Secondary	Diabetes self-efficacy/empowerment		6 months	No
Secondary	Diabetes knowledge		6 months	No